Blue Bell Private Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Blue Bell Private Wealth Management's BMY Position: Q1 2026 in Review
Blue Bell Private Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.25% in Q1 2026, buying an estimated $117 and bringing the position to 798 shares worth $48.4K. The position accounts for 0.01% of the portfolio, ranked #415.
Blue Bell Private Wealth Management first reported a position in BMY in Q4 2013 and has held it in 30 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Blue Bell Private Wealth Management held 798 shares of Bristol-Myers Squibb worth $48.4K as of Q1 2026.
- Blue Bell Private Wealth Management bought 2 Bristol-Myers Squibb shares in Q1 2026, an estimated $117.
- Bristol-Myers Squibb made up 0.01% of Blue Bell Private Wealth Management's portfolio in Q1 2026, its #415 holding.
- Blue Bell Private Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 30 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Blue Bell Private Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.